93 7441 (Divalproex sodium delayed-release 500 mg)

Pill imprint 93 7441 has been identified as Divalproex sodium delayed-release 500 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; hyperekplexia; epilepsy (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7441

Divalproex sodium delayed-release 500 mg 93 7441
Divalproex sodium delayed-release
Imprint:
93 7441
Strength:
500 mg
Color:
Orange
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7441
Inactive Ingredients:
ammonia
crospovidone
hypromellose 2910 (6 mPa.s)
hypromellose phthalate (31% phthalate, 40 cst)
ferrosoferric oxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 3350
polyvinyl alcohol
povidone k30
corn starch
propylene glycol
shellac
silicon dioxide
magnesium silicate
titanium dioxide
triethyl citrate
ferric oxide red
ferric oxide yellow
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)